Navigation Links
Neogen Partners With Chinese Government
Date:6/2/2009

LANSING, Mich., June 2 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that its Scotland-based European subsidiary has signed a partnership agreement with the Chinese government to research China-specific food safety and plant health issues.

The partnership agreement created a jointly funded laboratory in Beijing. Testing methods and data developed in this lab will be used by more than 30 other labs throughout China.

"This agreement represents a great opportunity for Neogen to be at the forefront in helping develop food safety and plant health solutions specifically for the Chinese," said James Herbert, Neogen's CEO. "This opportunity is a logical expansion of Neogen Europe's proven ability to tailor solutions to the varying regulatory and quality assurance environments in the large number of countries it serves."

A recent high-level meeting between Chinese Minister of Quality Supervision, Inspection and Quarantine, Wang Yong, Scotland's First Minister, the United Kingdom's Ambassador to China, Sir William Ehrman, and Neogen representatives, led to the final agreement.

"This is fantastic news for Neogen Europe, Scottish jobs and businesses and for our international reputation," said Scotland's First Minister Alex Salmond, in a news release. "The pace of progress following our meeting with Mr. Yang in China last month is a remarkable testament to the impressive work of Neogen Europe, the potential for Scottish businesses in China and the lasting cooperation built."

According to the Scottish government, the agreement is expected to bring an economic boost of more than 10 million pounds to Scotland, paving the way for increased exports to China, driving expansion in Scotland and solidifying Scotland's reputation for world-leading sciences.

The company's Neogen Europe subsidiary, based in Ayr, Scotland, does research and development of diagnostic tests for plant diseases and food safety, and also markets products from other Neogen locations. Neogen Europe was honored last year with the Queen's Award for Enterprise -- the most prestigious business award in the United Kingdom.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.


'/>"/>
SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Acquires Kane Enterprises
2. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
3. Neogen Acquires Assets of Rivard Instruments
4. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
5. Neogen Launches Quickest Test Available for Tetracyclines in Milk
6. NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
7. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results
8. Neogen Reports 34% Increase in Net Income, 20% Increase in Revenues
9. NeoGenomics Files Annual Report on Form 10-KSB with the SEC
10. NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008
11. Neogen Forms Mexican Subsidiary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... 2017 Kurzlehrgang mit Fokus ... Zelltherapie-Studien, Poster legt metaproteomische Analyse des Darm-Mikrobioms bei Säuglingen ... ... Dr. Yoav Peretz , Scientific Director bei ImmuneCarta, ... Assays zum Nachweis intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien im ...
(Date:2/18/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The report provides separate comprehensive analytics for the US, ... Rest of World. Annual estimates and forecasts are provided for the ... for these markets. Market data and analytics are derived from primary ...
(Date:2/17/2017)... 17, 2017  If only one in every ... mutation-conferring resistance to chemotherapy, thousands of cancer cells ... focused on finding these mutations in ever-smaller subpopulations ... tumor DNA in blood — to guide treatment ... Unfortunately, however, detecting these genetic anomalies may ...
(Date:2/16/2017)... ... 16, 2017 , ... EIT Digital has launched work to develop ... Pilot studies are about to get under way for the framework, which is designed ... The concept is expected to be transferred eventually to other industries that also require ...
Breaking Biology Technology:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
Breaking Biology News(10 mins):